4/A
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-034496
Director acquired 21,552 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krebs Andreas Director | 2022-06-01 | Grant or award | +21,552 | 21,552 | D | ||
| Derivatives | |||||||
| Krebs Andreas Director | 2022-06-01 | Grant or award · Stock Option (Right to Buy) | +133,744 | 175,508 | D | ||
| Krebs Andreas Director | 2022-06-01 | Grant or award · Director's Deferred Share Units | +98,198 | 139,962 | D | ||
| Krebs Andreas Director | 2022-06-01 | Grant or award · Director's Deferred Share Units | +717,937 | 759,701 | D | ||
| Krebs Andreas Director | 2022-06-01 | Grant or award · Director's Deferred Share Units | +28,628 | 68,392 | D | ||
Loading xslF345X03/doc4a.xml…